Indication

X-linked adrenoleukodystrophy

X-linked adrenoleukodystrophy is a rare, inherited peroxisomal metabolic disorder caused by pathogenic variants in the ABCD1 gene, which impairs the beta-oxidation of very long-chain fatty acids. Read more about X-linked adrenoleukodystrophy

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common X-linked adrenoleukodystrophy therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with X-linked adrenoleukodystrophy preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About X-linked adrenoleukodystrophy.

X-linked adrenoleukodystrophy is a rare, inherited peroxisomal metabolic disorder caused by pathogenic variants in the ABCD1 gene, which impairs the beta-oxidation of very long-chain fatty acids.

This metabolic defect leads to systemic accumulation of these fatty acids, primarily targeting the white matter of the central nervous system, peripheral nerves, and the adrenal cortex.

While primarily affecting hemizygous males, heterozygous females may also exhibit manifestations with advancing age.

Clinical presentations range across distinct phenotypes, including rapidly progressive inflammatory cerebral demyelination leading to profound cognitive and motor deficits, a slowly progressive adult-onset myelopathy and axonopathy termed adrenomyeloneuropathy, and primary adrenocortical insufficiency.

Personalize your experience

Follow X-linked adrenoleukodystrophy and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it